Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hitt

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
The Senior Care Pharmacist|February 27, 2025
Brexpiprazole: A Balance of Risks and BenefitsEmily M Hitt
Connecticut Medicine|December 1, 1995
Metformin: an alternative treatment for noninsulin-dependent diabetes mellitusC M Hitt
The Annals of Pharmacotherapy|March 27, 2024
Rozanolixizumab: A New Therapy in the Treatment of Myasthenia GravisEmily M Hitt
Clinical Therapeutics|May 2, 2024
Zuranolone: A Narrative Review of a New Oral Treatment for Postpartum DepressionEmily M Hitt
Current Pharmaceutical Design|May 2, 2000
Gene vectors for cytokine expression in vivoM M Hitt, J Gauldie
International Journal of Molecular Sciences|November 26, 2020
The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to CancerQuinn Storozynsky, Mary M Hitt
The New England Journal of Medicine|June 5, 1986
Toad toxicityM Hitt, D D Ettinger
Current Gene Therapy|August 17, 2005
Transcriptionally targeted adenovirus vectorsHamid Sadeghi, Mary M Hitt
Virology|December 1, 1990
Adenovirus E1A under the control of heterologous promoters: wide variation in E1A expression levels has little effect on virus replicationM M Hitt, F L Graham
Chemical Reviews|October 8, 2011
Acceleration of conjugated dienyne cycloaromatizationDavid M Hitt, Joseph M O'Connor
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
The Senior Care Pharmacist|February 27, 2025
Brexpiprazole: A Balance of Risks and BenefitsEmily M Hitt
Connecticut Medicine|December 1, 1995
Metformin: an alternative treatment for noninsulin-dependent diabetes mellitusC M Hitt
The Annals of Pharmacotherapy|March 27, 2024
Rozanolixizumab: A New Therapy in the Treatment of Myasthenia GravisEmily M Hitt
Clinical Therapeutics|May 2, 2024
Zuranolone: A Narrative Review of a New Oral Treatment for Postpartum DepressionEmily M Hitt
Current Pharmaceutical Design|May 2, 2000
Gene vectors for cytokine expression in vivoM M Hitt, J Gauldie
International Journal of Molecular Sciences|November 26, 2020
The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to CancerQuinn Storozynsky, Mary M Hitt
The New England Journal of Medicine|June 5, 1986
Toad toxicityM Hitt, D D Ettinger
Current Gene Therapy|August 17, 2005
Transcriptionally targeted adenovirus vectorsHamid Sadeghi, Mary M Hitt
Virology|December 1, 1990
Adenovirus E1A under the control of heterologous promoters: wide variation in E1A expression levels has little effect on virus replicationM M Hitt, F L Graham
Chemical Reviews|October 8, 2011
Acceleration of conjugated dienyne cycloaromatizationDavid M Hitt, Joseph M O'Connor
Pageof 10